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Abstract
Background: Public adherence to influenza vaccination recommendations has been low, particularly among younger adults
and children under 2, despite the availability of safe and effective seasonal vaccine. Intention to receive 2009 pandemic
influenza A (H1N1) vaccine has been estimated to be 50% in select populations. This report measures knowledge of and
intention to receive pandemic vaccine in a population-based setting, including target groups for seasonal and H1N1
influenza.
Methodology and Principal Findings: On August 28–29, 2009, we conducted a population-based survey in 2 counties in
North Carolina. The survey used the 3067 two-stage cluster sampling methodology to identify 210 target households.
Prevalence ratios (PR) and 95% confidence intervals (CI) were estimated. Knowledge of pandemic influenza A (H1N1) vaccine
was high, with 165 (80%) aware that a vaccine was being prepared. A total of 133 (64%) respondents intended to receive
pandemic vaccine, 134 (64%) intended to receive seasonal vaccine, and 109 (53%) intended to receive both. Reporting great
concern about H1N1 infection (PR 1.55; 95%CI: 1.30, 1.85), receiving seasonal influenza vaccine in 2008–09 (PR 1.47; 95%CI:
1.18, 1.82), and intending to receive seasonal influenza vaccine in 2009–10 (PR 1.27; 95%CI: 1.14, 1.42) were associated with
intention to receive pandemic vaccine. Not associated were knowledge of vaccine, employment, having children under age
18, gender, race/ethnicity and age. Reasons cited for not intending to get vaccinated include not being at risk for infection,
concerns about vaccine side effects and belief that illness caused by pandemic H1N1 would be mild. Forty-five percent
of households with children under 18 and 65% of working adults reported ability to comply with self-isolation at home for
7–10 days if recommended by authorities.
Conclusions and Significance: This is the first report of a population based rapid assessment used to assess knowledge and
intent to receive pandemic vaccine in a community sample. Intention to receive pandemic and seasonal vaccines was
higher than previously published reports. To reach persons not intending to receive pandemic vaccine, public health
communications should focus on the perceived risk of infection and concerns about vaccine safety.
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Introduction
OnApril 26, 2009, the Acting Secretary of the US Department of
Health and Human Services declared a public health emergency
related to the emergence and spread of a novel influenza A (H1N1)
virus initially identified in California and Texas. North Carolina
reported its first confirmed case of infection with the 2009 pandemic
influenza A (H1N1) virus (pandemic H1N1) on May 3, 2009. By
June, the World Health Organization had declared a phase 6
pandemic, indicating global spread. North Carolina continued to
report widespread influenza activity into the fall of 2009.
Vaccination is considered to be an effective method for
preventing influenza and influenza-related complications. Soon
after the pandemic H1N1 virus was identified, it was recognized
that the 2009–2010 seasonal vaccine was not likely to be protective
against infection with the novel virus [1]. Pandemic H1N1
monovalent vaccine, produced by the same manufacturers and in
the same way as the seasonal vaccine, was made available
nationally beginning in October 2009. Two presentations of new
vaccine were produced in the United States; a nasal spray live
attenuated influenza vaccine and an inactivated vaccine admin-
istered by intramuscular injection [2].
The U.S. Centers for Disease Control and Prevention (CDC)
have released recommendations for the use of pandemic H1N1
vaccine in the United States [3]. The five initial target groups are
estimated to include 159 million persons who should be the first to
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receive vaccine. These include pregnant women, persons who live
with or provide care for infants aged ,6 months, health-care and
emergency medical services personnel, children and young adults
aged 6 months–24 years, and persons aged 25–64 years who have
medical conditions that put them at higher risk for influenza-
related complications. Additional groups should be vaccinated as
supply allows.
In the United States, public adherence to influenza vaccination
recommendations has been low in recent years despite the
availability of safe and effective seasonal influenza vaccine. While
83% of the United States population is included in one or more of
the target groups for whom seasonal influenza vaccination is
recommended, only 33% received an influenza vaccination during
the 2008–09 influenza season [4]. Few young adults are targeted
for seasonal vaccine, and uptake among healthy persons 18 years
to 49 years in 2008 was poor at 20% [5].
Several studies have examined the intention to receive
pandemic H1N1 vaccine. In an internet panel survey conducted
by RAND Corporation (www.rand.org) in May and June 2009,
49.6% of adults indicated intention to receive the pandemic H1N1
vaccine [6]. Intention to receive pandemic H1N1 vaccine was
strongly associated with intention to receive seasonal vaccine;
those who indicated they would receive seasonal vaccine in 2009–
10 were twice as likely to report intention to receive pandemic
H1N1 vaccine.
A telephone survey conducted by Harvard University research-
ers in September 2009 concluded that 40% of adults were
absolutely certain they would receive the pandemic H1N1 vaccine
and 51% of parents were absolutely certain they would vaccinate
their children [7]. A San Francisco-based poll of registered voters
reported that 72% of respondents would be likely to get the
vaccine if their physician or public health officials recommended
it, although only 51% of respondents were very worried about
H1N1. Women and Latinos included in the poll expressed higher
levels of concern than men and respondents of other races/
ethnicities [8].
To mount an effective public health response, officials in North
Carolina needed to know more about the intent of North
Carolinians, particularly those in target groups, to receive the
pandemic H1N1 vaccine before the vaccine was made available
for distribution. In addition to understanding more about the
population’s intent to be vaccinated for seasonal influenza, officials
also needed to know more about residents’ knowledge and
concerns about pandemic H1N1 vaccine, sources of health
information, and likelihood of following self-isolation recommen-
dations.
The North Carolina Center for Public Health Preparedness and
the North Carolina Preparedness and Emergency Response
Research Center at the University of North Carolina Gillings
School of Global Public Health partnered with the North Carolina
Division of Public Health to conduct a population-based survey in
2 North Carolina counties. The purpose of the survey was to
determine the intent of the population to receive the pandemic
H1N1 and seasonal influenza vaccines in fall 2009, ability to
comply with recommended isolation and social distancing
measures, and the sources by which residents received health
information about pandemic influenza A (H1N1).
Methods
Two counties in North Carolina were selected for inclusion in
the study, based on proximity to the University of North Carolina
at Chapel Hill and diversity of their populations. Both counties are
approximately 80% white, non-Hispanic and have similar
population density. Orange County, home to the University, has
a high median household income, high home values, and a high
percentage of the population with at least a bachelor’s degree
when compared to North Carolina averages. Alamance County
has a higher percentage of African-American residents than
Orange County and a higher percentage of Hispanic residents
than Orange County or the state as a whole.
In order to quickly collect actionable data, a rapid needs
assessment was conducted using the CDC-validated 3067 two-
stage cluster sampling methodology to identify 210 target
households [9]. This random household cluster sampling scheme
has been validated and used effectively for rapid assessment and
estimation of a variety of population-level public health needs.
Maps of the 2 counties that delineate each lot by land ownership
were obtained from the respective county governments, and 30
census block groups (the second smallest geographic subdivision
for which the U.S. Census Bureau tabulates sample data) in the 2
counties were randomly selected based on probability proportion-
ate to population size sampling. Within each selected block group,
7 interview locations were chosen from a simple random sample of
all existing parcels using a geographic information systems-based
(GIS) survey site selection toolkit developed by the North Carolina
Division of Public Health in ESRI ArcMap 9.2 (Redlands, CA).
Surveys were implemented on Friday, August 28 and Saturday,
August 29, 2009 via in-person interviews with 1 adult member
of each selected household. Interviews were conducted between
10 a.m.–6 p.m. Data were electronically recorded during the
interview using global positioning systems-equipped Trimble
Recon field data collectors. Two-person interviewer teams,
including student volunteers from the UNC Gillings School of
Global Public Health’s Team Epi-Aid program and health
department staff members, were routed to each location with a
map generated with ESRI ArcPad 6.0.3 Street Map USA
(Redlands, CA). Interview teams assigned to census blocks with
large Hispanic populations included a Spanish speaker, and a
translated survey instrument was available. Oral informed consent
was obtained from each respondent. This research received
approval by the Institutional Review Board of the University of
North Carolina at Chapel Hill Gillings School of Global Public
Health (Public Health IRB #09-1518).
The survey included 26 questions and took 15 minutes to
administer (Appendix S1). Intention to receive seasonal and
pandemic H1N1 vaccine was measured by asking respondents to
report whether or not they intended to get vaccinated when each
vaccine was available. For each vaccine, if respondents indicated
that they intended to get vaccinated, interviewers read a list of
reasons and asked respondents to indicate if each reason applied to
them. A similar procedure was followed for those who reported
that they did not intend to be vaccinated. Those intending to be
vaccinated were asked in what venue they would receive the
vaccination. Knowledge of pandemic influenza vaccination was
assessed by asking respondents if they were aware that an H1N1
(swine flu) vaccine was being prepared and if they were aware that
2 separate doses of this vaccine might be recommended. Concern
about pandemic H1N1 was measured by asking respondents to
report whether they were very concerned, somewhat concerned,
or not at all concerned about H1N1 infection.
Next, respondents were asked about conditions that could
facilitate or hinder compliance with recommended isolation and
social distancing measures recommended by the North Carolina
Division of Public Health. First, respondents reported their
employment status and whether or not they had children under
the age of 18 living at home. Those reporting full- or part-time
employment were asked whether or not they had paid sick leave.
Intent to Receive H1N1 Vaccine
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All respondents were asked the number of days they would be able
to stay home, away from people who were not a part of their
household, if they were infected with H1N1 and self-isolation was
recommended by health authorities. Those with children under 18
years of age were asked to categorize the age of the children (,6
months, 6 months to 4 years, 5 years to 17 years) and to indicate if
their children attended school or day care and their intention to
vaccinate their children against H1N1. Respondents with children
were asked to report the number of days they would be able to
keep their child(ren) at home, away from people who were not a
part of their household, if their child was infected with H1N1.
Interviewers read a list of potential sources of information about
pandemic H1N1 to respondents, who indicated whether they had
received any information from each. Limited demographic data,
including gender, age, race, and ethnicity, were also collected.
Bivariate analyses were performed using generalized linear
models to identify associations between intention to receive
pandemic H1N1 vaccine and demographic, knowledge, and
behavioral variables. Prevalence ratios (PR) and 95% confidence
intervals (CI) were estimated. All statistical analyses were
conducted in SAS 9.1.3 (Cary, NC).
Results
Of 258 households visited in the population-based survey,
individuals from 207 households completed the survey (response
rate = 80%). The median age of respondents was 49 years (range
18–92 years), 56% were female (n = 115), and the majority were
white, non-Hispanic (n = 140).
A total of 133 (64%) respondents reported that they intended to
receive pandemic H1N1 vaccine (Table 1) and 109 (53%) intended
to receive both pandemic H1N1 and seasonal influenza vaccines
[10]. Knowledge of pandemic H1N1 vaccine, age, gender, race/
ethnicity, work status, and having children under age 18 living at
Table 1. Factors potentially associated with intent to receive pandemic H1N1 vaccination, North Carolina, 2009 (N = 207).
Variable Description
Intend to Receive Pandemic
Vaccine (n =133)
Do Not Intend to Receive
Pandemic Vaccine (n =74) Prevalence Ratio (95% CI)
n % n %
Knowledge of Pandemic Vaccine
No/Don’t Know 30 71.43 12 28.57 REF
Yes 103 62.42 62 37.58 1.09 (0.95, 1.25)_
Level of Concern
Not at all Concerned 26 45.61 31 54.39 REF
Somewhat Concerned 57 61.96 35 38.04 0.94 (0.76, 1.15)
Very Concerned 50 86.21 8 13.79 1.55 (1.30, 1.85)
Received Seasonal Flu Vaccine in 2008–09
No 53 51.96 49 48.04 REF
Yes 80 76.19 25 23.81 1.47 (1.18, 1.82)
Intend to Receive Seasonal Flu Vaccine in 2009–10
No 24 32.00 51 68.00 REF
Yes 109 76.76 23 23.24 1.27 (1.14, 1.42)
Employment Status
Homemaker, Student, Retired, Disabled, Unemployed 75 68.81 34 31.19 REF
Work Full- or Part-Time 58 59.18 40 40.82 0.86 (0.70, 1.06)
Children in Home
No 85 63.91 48 36.09 REF
Yes 48 64.86 26 35.14 0.96 (0.80, 1.22)
Gender
Female 71 61.74 44 38.26 REF
Male 61 67.03 30 32.97 1.07 (0.87, 1.31)
Missing 1 100.00 0 0.00
Race/Ethnicity
White, Non-Hispanic 87 62.14 53 37.86 REF
Other 46 69.70 20 30.30 1.12 (0.91, 1.38)
Missing 0 0.00 1 100.00
Age
18–24 14 61.54 8 38.46 REF
25–64 88 63.77 50 36.23 0.96 (0.78, 1.19)
65 and over 31 65.96 16 34.04 1.03 (0.81, 1.30)
CI = Confidence interval.
doi:10.1371/journal.pone.0011226.t001
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home were not significantly associated (p,0.05) with the
respondent’s intention to receive pandemic H1N1 vaccine. Those
who reported receiving the seasonal influenza vaccine in 2008–09
were 1.47 (95%CI: 1.18, 1.82) times as likely to report intention to
receive pandemic H1N1 vaccine. Respondents who reported that
they intended to receive seasonal influenza vaccine in 2009–10
were 1.27 (95%CI: 1.14, 1.42) times as likely to report intention to
receive pandemic H1N1 vaccine. Those who reported that they
were very concerned about being infected with pandemic H1N1
were 1.55 (95%CI: 1.30, 1.85) times as likely to report intention to
receive pandemic H1N1 vaccine compared with those who were
not at all or only somewhat concerned with infection.
The association between seasonal influenza vaccination and
intention to receive pandemic H1N1 vaccine was only significant
among those 25–64 years of age. Respondents in that age group
who reported receiving the seasonal influenza vaccine in 2008–09
were 1.54 (95% CI: 1.19, 1.98) times as likely to report intention to
receive pandemic H1N1 vaccine while those between 18 and 24
and those over age 65 were not significantly more likely to report
intention to receive H1N1 based on receiving seasonal influenza
vaccine in the prior year. When considering intention to receive
seasonal vaccine this year, those age 25–64 intending to receive
seasonal vaccine in 2009–10 were 1.33 (95% CI: 1.17, 1.51) times
as likely to report intention to receive pandemic H1N1 vaccine
while those between 18 and 24 and those over age 65 were not
significantly more likely to report intention to receive H1N1 based
on intention to receive seasonal influenza vaccine in the current
year. Among those who reported that they were very concerned
about being infected with pandemic H1N1, those age 25–64 were
1.50 (95% CI: 1.20, 1.88) times as likely to report intention to
receive pandemic H1N1 vaccine while those over age 65 were
1.56 (95% CI: 1.12, 2.18) times as likely to report intention to
receive pandemic H1N1 vaccine.
A total of 132 (64%) respondents reported that they intended to
receive seasonal influenza vaccine (Table 2). Those who reported
receiving seasonal vaccine during the 2008–09 influenza season
were 3.04 (95%CI: 2.27, 4.06) times as likely to report intention to
receive seasonal vaccine in 2009–10. When stratified by age group,
the association between past seasonal influenza vaccination and
intention to receive seasonal vaccine was only significant among
those 25–64, who were 3.34 (95% CI: 2.34, 4.77) times as likely to
report intention to receive seasonal vaccine based on seasonal
vaccine receipt in the previous year. Those who reported that they
intended to receive pandemic H1N1 vaccine in 2009–10 were
2.64 (95%CI: 1.86, 3.74) times as likely to report that they
intended to receive seasonal vaccine this year. When stratified by
age group, the association between intention to receive pandemic
H1N1 vaccine and intention to receive seasonal vaccine was only
significant among those 25–64, who were 2.76 (95% CI: 1.74,
4.37) times as likely to report intention to receive seasonal vaccine
based on intention to receive pandemic H1N1 vaccine. Level of
concern about contracting pandemic H1N1 was also significantly
associated with intention to receive 2009–10 seasonal vaccine
(PR=1.24; 95% CI: 1.02, 1.52). Knowledge of pandemic H1N1
vaccine, gender, race/ethnicity, and having children under age 18
living at home were not significantly associated (p,0.05) with the
respondent’s intention to receive seasonal vaccine.
Those who reported working either part- or full-time were only
0.75 (95%CI: 0.60, 0.93) times as likely to report intention to
receive the seasonal vaccine in the 2009–10 influenza season as
compared to those who were homemakers, students, disabled,
retired or unemployed. Importantly, those age 65 and over were
1.42 (95%CI: 1.18, 1.71) times as likely as adults between 18–24
years to report intention to receive seasonal vaccine, consistent
with public health recommendations for seasonal vaccine that
include all adults over age 65 [11]. Respondents between the ages
of 25 and 64 were 0.81 (95% CI: 0.66, 0.98) times as likely to
report intention to receive seasonal vaccine in 2009–10 compared
to those 18–24 years of age.
Most respondents (n = 165; 80%) were aware prior to the
interview that a pandemic H1N1 vaccine was in production.
However, the proportion who intended to receive pandemic
H1N1 vaccine was similar among those who were and were not
aware that the vaccine was in production. While only 75 (36%)
respondents were aware the pandemic H1N1 vaccine may require
2 doses, this awareness was not associated with intent to receive
the vaccine. More than two-thirds of respondents (n = 132; 64%)
reported they knew where they intended to get the H1N1 vaccine,
with most (n = 62) planning to get the vaccine at the physician’s
office. Twenty-one reported planning to get the vaccine at their
local health department, while 20 planned to get vaccinated at
their place of employment. Sixty percent (n = 125) of those
surveyed reported having private health insurance, while 26%
(n= 53) were covered by Medicare or Medicaid and 13% (n= 27)
were uninsured. Neither the location where the respondent
intended to get the pandemic H1N1 vaccine nor their insurance
status was significantly associated with intention to receive the
pandemic H1N1 vaccine.
When asked to report whether each of a list of reasons for not
receiving the pandemic H1N1 vaccine applied to them, the most
common reason given for not intending to receive seasonal vaccine
was the belief that they would not be infected (16%).
Seventy-four (36%) of households reported a child or children
under age 18 living at home including 5 infants less than 6 months
old, 30 children between 6 months and 4 years and 59 children
between 5 and 18 years old. Sixty-three (85%) households with
children reported that their children attended day care or school.
Of those with children less than 18 years old living at home, 48
(65%) households reported that they intended to vaccinate their
child or children with the H1N1 vaccine. Importantly, of the 5
respondents who reported a child at home less than 6 months of
age, 4 (80%) reported that they intended to vaccinate these infants,
who are not eligible to receive the vaccine. Respondents reported
intention to vaccinate 22 (73%) children between 6 months and 4
years of age and 36 (61%) children between 5 and 18 years of age
with the H1N1 vaccine. Forty-five (61%) households expressed
intent to vaccinate their children with both vaccines, including
63% among households with children between 6 months and 4
years of age and 46% among households with children between 5
and 18 years of age. Thirty-three (45%) of those with children
under 18 in their household reported being able to keep their
children at home and away from people who were not a part of
their household for 7–10 days or as long as necessary.
Forty-seven percent (n = 98) of respondents reported being
employed either full-time or part-time. Of those who reported full-
or part-time employment, 41% (n= 40) did not have access to paid
sick leave. However, 65% (n= 64) of those who were employed
full- or part-time reported that they could stay at home and away
from people who were not a part of their household for 7–10 days
or as long as necessary.
Discussion
This study found some similarities and differences regarding
intent to receive vaccination for pandemic H1N1 in comparison to
previous studies. Consistent with previous reports, intent to
comply with recommendations for pandemic H1N1 vaccine was
associated with past history of and intent to receive seasonal
Intent to Receive H1N1 Vaccine
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influenza vaccine [12]. Current knowledge of and intention to
receive both the 2009–2010 pandemic H1N1 and seasonal
vaccines were generally higher than those reported in other
studies. This is most likely due to the widespread media coverage
of the H1N1 pandemic and the vaccine since the other studies
were conducted in spring of 2009 and the fact that previously
published studies relied on telephone- and internet-based survey
rather than face-to-face interviews, which have been demonstrated
to increase social desirability bias with regard to reported
adherence to health guidelines and other health behaviors [13].
The percentage of those who intended to get vaccinated in this
population-based survey are higher for both vaccines than the
uptake estimated for the seasonal vaccine in 2006, which ranged
from 15% in non-target and 32% in target persons over 6 months
of age [14]. Notably, the intent to receive pandemic H1N1 vaccine
in adults over age 65, who were not included in the initial target
groups for this vaccine, is high (66%) in this study, and similar to
the probability of being vaccinated against H1N1 (63%) reported
by Maurer [15]. However, the estimated uptake rate for seasonal
vaccine among those age 65 or over in this study was 83%, much
higher than in other age groups. Given concerns regarding
availability of paid sick leave and perceived ability to comply with
community mitigation strategies (e.g., self-isolation, social distanc-
ing, school dismissal) vaccination is becoming an increasingly
critical part of the public health strategy aimed at reducing
morbidity and mortality due to pandemic H1N1.
Only 3 target groups could be specifically examined using the
data collected. Since children less than 6 months of age are at high
risk of influenza-related complications and cannot be vaccinated, it
is recommended that their caregivers receive the H1N1 vaccine.
Table 2. Factors potentially associated with intention to receive vaccination for seasonal influenza, North Carolina, 2009 (N = 207).
Variable Description
Intend to Receive Seasonal Vaccine
(n =132)
Do Not Intend to Receive Seasonal
Vaccine (n =75)
Prevalence Ratio
(95% CI)
n % n %
Knowledge of Pandemic Vaccine
No/Don’t Know 27 64.29 15 35.71 REF
Yes 105 63.63 60 36.37 1.00 (0.85, 1.18)
Level of Concern
Not at all Concerned 28 49.12 29 50.88 REF
Somewhat Concerned 61 66.30 31 33.70 1.07 (0.88, 1.32)
Very Concerned 43 74.14 15 25.86 1.24 (1.02, 1.52)
Received Seasonal Flu Vaccine in 2008–09
No 32 31.37 70 68.63 REF
Yes 100 95.24 5 4.76 3.04 (2.27, 4.06)
Intend to Receive Pandemic Vaccine in 2009–10
No 23 31.08 51 68.92 REF
Yes 109 81.95 24 18.05 2.64 (1.86, 3.74)
Employment Status
Homemaker, Student, Retired, Disabled,
Unemployed
79 72.48 30 27.52 REF
Work Full-or Part-Time 53 54.08 45 45.92 0.75 (0.60, 0.93)
Children in Home
No 86 64.66 47 35.34 REF
Yes 46 62.16 28 37.84 1.04 (0.84, 1.29)
Gender
Female 73 63.48 42 36.52 REF
Male 58 63.74 33 36.26 0.99 (0.80, 1.22)
Missing 1 100.00 0 0.00
Race/Ethnicity
White, Non-Hispanic 93 66.43 47 33.57 REF
Other 39 59.09 27 40.91 0.91 (0.72, 1.15)
Missing 0 0.00 1 100.00
Age
18–24 12 54.55 10 45.45 REF
25–64 82 59.42 56 40.58 0.81 (0.66, 0.98)
65 and over 39 82.98 8 17.02 1.42 (1.18, 1.71)
Missing 0 0.00 1 100.00
CI = Confidence interval.
doi:10.1371/journal.pone.0011226.t002
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In this study, 80% (4/5) of respondents with infants in the home
reported an intention to be vaccinated. Similarly, since many cases
have occurred in school and day care settings and among healthy
young adults, children between 6 months and 18 years old and
young adults between 19 and 24 years of age are also encouraged
to receive the vaccine. However, parents reported lower intention
to vaccinate their older children and fewer young adults reported
an intention to be vaccinated as recommended.
At this time of this study, self-isolation at home for a period of
7–10 days after symptom onset or 24 hours after resolution of
fever (whichever is longer) was recommended by the North
Carolina Division of Public Health for all persons with influenza-
like illness. Nearly half of all families with children under age 18
living at home indicated that they could keep children at home,
away from school or day care for at least 7–10 days. However, by
the time of the survey’s implementation, school dismissals, which
were prevalent in the spring of 2009, were being recommended
only for schools where all or most students were at high risk [16].
Similarly, 65% of those who worked part- or full-time indicated
that they could stay home, away from work, for this amount of
time. Those who are self-employed may be able to miss work for
this period of time without sanction from their employer; however,
they may forego income during this time. Legislative efforts to
provide 5 days of sick leave benefits to all U.S. workers with H1N1
pandemic influenza have been unsuccessful to date [17].
Reasons cited for not intending to get vaccinated included not
believing themselves to be at risk for infection, concern about side
effects of the vaccine, and the belief that illness caused by
pandemic H1N1 was likely to be mild. These same reservations
have been expressed in studies conducted in Canada and Australia
that examined attitudes toward pandemic vaccines and pandemic
influenza [18,19].
Importantly, most information received about pandemic H1N1
is from television sources. While the target groups for the
pandemic H1N1 vaccine are different than those for seasonal
influenza vaccine, this population-based survey indicates intention
to receive pandemic vaccine is similar for adults in all age groups
and for households with children. Since a relatively small number
of respondents (n = 23) indicated that they were not included in a
target group for the H1N1 vaccine, it seems likely that respondents
were unaware of the target groups for this new vaccine. Similarly,
only about one-third knew that two doses of vaccine may be
recommended, suggesting that specific information regarding the
vaccine had not been widely disseminated by the television media
by the time of the assessment.
This study had several limitations. The study was cross-sectional
and can only provide a picture of the population at a given point in
time. This may be particularly important in this case, as pandemic
H1N1 has been covered extensively in the media and attitudes and
awareness may be affected with the amount of attention. The
media attention surrounding the H1N1 pandemic is much more
extensive than that seen during a usual influenza season. Also, due
to the nature and the timing of the survey, respondents were asked
to report their intention to receive both pandemic and seasonal
vaccines. Reported intentions cannot be confirmed, and results
may have been different if the pandemic vaccine had been
available at the time of the survey. Finally, while these results are
generalizable to the 2 county study area, no conclusions can be
drawn about the intention to receive vaccine among the total
population of North Carolina or any other group.
While the sample size of this study is small, the rapid needs
assessment methodology is designed to be representative of the source
population and has been widely validated [9,20,21,22,23]. However,
if those who are most likely to be suspect of or refuse vaccination are
also more likely to be missed in this survey (e.g., because they did not
answer the door or declined to participate in the survey) there is
potential for response bias. To minimize this problem, interviews
were conducted on weekends and weekdays during both day and
early evening hours and interviewers identified themselves as working
with both the university and the health department.
As this pandemic unfolds, public health practitioners are grappling
with many additional questions related to vaccine implementation
and much remains for further study. Future research should examine
pandemic H1N1 vaccine uptake in the population, particularly
among target groups. Although longitudinal follow-up of the same
individuals before and after vaccine implementation would be ideal,
the rapid assessment methodology provides a representative sample
of the study population, so future studies could use similar
methodology for valid comparison using cross-sectional data.
Additional studies should measure success of public health messaging
related to pandemic H1N1 vaccine target groups, vaccine safety, and
vaccine distribution. Lessons learned from public messaging around
H1N1 may be applied to other large-scale public health events, as
well as to annual seasonal influenza communication. Investigating
these issues will help with effectively and efficiently preparing for and
responding to the next influenza pandemic.
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